Evidence‐based treatment of systemic vasculitis
Open Access
- 1 June 2000
- journal article
- review article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 39 (6) , 585-595
- https://doi.org/10.1093/rheumatology/39.6.585
Abstract
Vasculitis/Series Editor: R. WattsKeywords
This publication has 81 references indexed in Scilit:
- Selective high dose gamma-globulin treatment in Kawasaki disease: Assessment of clinical aspects and cost effectivenessPediatrics International, 1999
- Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences between patients with anti‐proteinase 3 and anti‐myeloperoxidase autoantibodiesJournal of Internal Medicine, 1998
- Pulmonary-Renal SyndromeSeminars in Respiratory and Critical Care Medicine, 1998
- Trimethoprim–Sulfamethoxazole (Co-Trimoxazole) for the Prevention of Relapses of Wegener's GranulomatosisNew England Journal of Medicine, 1996
- Neutrophil and recombinant myeloperoxidase as antigens in ANCA positive systemic vasculitisClinical and Experimental Immunology, 1995
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Clinical Features and Outcome in Patients with Glomerulonephritis and Antineutrophil Cytoplasmic AutoantibodiesNephron, 1993
- Wegener Granulomatosis: An Analysis of 158 PatientsAnnals of Internal Medicine, 1992
- Cyclophosphamide Therapy of Severe Systemic Necrotizing VasculitisNew England Journal of Medicine, 1979
- COMBINED IMMUNOSUPPRESSION AND ANTICOAGULATION IN RAPIDLY PROGRESSIVE GLOMERULONEPHRITISThe Lancet, 1975